C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited
- PMID: 9144462
C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited
Abstract
Complete deficiency of C1q is almost invariably associated with the development of systemic lupus erythematosus. It has been suggested that this association may result from a generalized failure to clear Ag-Ab complexes. However, it has not been demonstrated how such a broad impairment results in this specific and consistent autoimmune phenotype, in which photosensitive skin disease is the most prominent manifestation. We believe there is another role for the classical pathway in maintaining immune tolerance. Surface blebs of apoptotic keratinocytes are concentrated sources of autoantigens, and these packages may define a novel immune context and challenge self-tolerance if not properly cleared and processed. We demonstrate here that when human keratinocytes are rendered apoptotic, they also develop the capacity to specifically and directly bind to C1q in the absence of Ab. C1q may mediate Ab-independent clearance of apoptotic keratinocytes, and prevent immunization with autoantigens of cutaneous origin.
Similar articles
-
Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.Eur J Immunol. 2002 Jun;32(6):1726-36. doi: 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R. Eur J Immunol. 2002. PMID: 12115656
-
Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice.J Invest Dermatol. 2001 Jul;117(1):52-8. doi: 10.1046/j.0022-202x.2001.01381.x. J Invest Dermatol. 2001. PMID: 11442749
-
C1q, autoimmunity and apoptosis.Immunobiology. 2002 Sep;205(4-5):395-406. doi: 10.1078/0171-2985-00141. Immunobiology. 2002. PMID: 12396002 Review.
-
Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.J Immunol. 2009 Sep 1;183(5):3512-21. doi: 10.4049/jimmunol.0803573. Epub 2009 Jul 31. J Immunol. 2009. PMID: 19648280
-
Complement component c1q and anti-c1q antibodies in theory and in clinical practice.Scand J Immunol. 2008 May;67(5):423-30. doi: 10.1111/j.1365-3083.2008.02089.x. Epub 2008 Mar 17. Scand J Immunol. 2008. PMID: 18363591 Review.
Cited by
-
Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis.Front Immunol. 2020 Jul 2;11:1353. doi: 10.3389/fimmu.2020.01353. eCollection 2020. Front Immunol. 2020. PMID: 32714331 Free PMC article. Review.
-
Complement Component C1q Programs a Pro-Efferocytic Phenotype while Limiting TNFα Production in Primary Mouse and Human Macrophages.Front Immunol. 2016 Jun 15;7:230. doi: 10.3389/fimmu.2016.00230. eCollection 2016. Front Immunol. 2016. PMID: 27379094 Free PMC article.
-
Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice.Immunology. 2004 Sep;113(1):80-8. doi: 10.1111/j.1365-2567.2004.01940.x. Immunology. 2004. PMID: 15312138 Free PMC article.
-
Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences.J Clin Invest. 2001 Oct;108(7):957-62. doi: 10.1172/JCI14122. J Clin Invest. 2001. PMID: 11581295 Free PMC article. Review. No abstract available.
-
Ultraviolet-B recruits mannose-binding lectin into skin from non-cutaneous sources.J Invest Dermatol. 2005 Jul;125(1):166-73. doi: 10.1111/j.0022-202X.2005.23794.x. J Invest Dermatol. 2005. PMID: 15982317 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical